BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 27490411)

  • 21. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
    Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
    Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
    Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
    Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
    Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
    Salvalaggio P; Afonso RC; Pereira LA; Ferraz-Neto BH
    Einstein (Sao Paulo); 2012; 10(3):278-85. PubMed ID: 23386004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Yi Z; Mayorga ME; Orman ES; Wheeler SB; Hayashi PH; Barritt AS
    Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geographic inequity in access to livers for transplantation.
    Yeh H; Smoot E; Schoenfeld DA; Markmann JF
    Transplantation; 2011 Feb; 91(4):479-86. PubMed ID: 21200366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New paradigms for organ allocation and distribution in liver transplantation.
    Kalra A; Biggins SW
    Curr Opin Gastroenterol; 2018 May; 34(3):123-131. PubMed ID: 29465430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variability in acceptance of organ offers by pediatric transplant centers and its impact on wait-list mortality.
    Mitchell E; Loomes KM; Squires RH; Goldberg D
    Liver Transpl; 2018 Jun; 24(6):803-809. PubMed ID: 29506323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of MELD score in country with low organ donation.
    Limsrichamrern S; Mahawithitwong P; Sirivatanauksorn Y; Mitmanochai P
    J Med Assoc Thai; 2013 Aug; 96(8):924-8. PubMed ID: 23991598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies.
    Kling CE; Biggins SW; Bambha KM; Feld LD; Perkins JH; Reyes JD; Perkins JD
    JAMA Surg; 2023 Jun; 158(6):610-616. PubMed ID: 36988928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients.
    Ross K; Patzer RE; Goldberg DS; Lynch RJ
    Am J Transplant; 2017 Nov; 17(11):2879-2889. PubMed ID: 28695615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in access to the liver transplant waiting list in the United States.
    Mathur AK; Ashby VB; Fuller DS; Zhang M; Merion RM; Leichtman A; Kalbfleisch J
    Transplantation; 2014 Jul; 98(1):94-9. PubMed ID: 24646768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.
    Fosby B; Melum E; Bjøro K; Bennet W; Rasmussen A; Andersen IM; Castedal M; Olausson M; Wibeck C; Gotlieb M; Gjertsen H; Toivonen L; Foss S; Makisalo H; Nordin A; Sanengen T; Bergquist A; Larsson ME; Soderdahl G; Nowak G; Boberg KM; Isoniemi H; Keiding S; Foss A; Line PD; Friman S; Schrumpf E; Ericzon BG; Höckerstedt K; Karlsen TH
    Scand J Gastroenterol; 2015 Jun; 50(6):797-808. PubMed ID: 25959101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States.
    Heimbach JK; Hirose R; Stock PG; Schladt DP; Xiong H; Liu J; Olthoff KM; Harper A; Snyder JJ; Israni AK; Kasiske BL; Kim WR
    Hepatology; 2015 May; 61(5):1643-50. PubMed ID: 25644186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.